Genetic and functional profiling of Crohn's disease: Autophagy mechanism and susceptibility to infectious diseases

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Marcuzzi, Annalisa ^a   Bianco, Anna Monica ^a   Girardelli, Martina ^a   Tommasini, Alberto ^a   Martelossi, Stefano ^a   Monasta, Lorenzo ^a   Crovella, Sergio ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLAMMASOME; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AUTOPHAGY; CROHN DISEASE; DISEASE PREDISPOSITION; ENDOSCOPY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; IMMUNE RESPONSE; INFECTION; INTESTINE FLORA; LABORATORY TEST; MICROORGANISM; PATHOGENESIS; RADIOGRAPHY; REVIEW; TH1 CELL; TH17 CELL; ANIMAL; BIOLOGICAL MODEL; COMMUNICABLE DISEASE; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; AUTOPHAGY; COMMUNICABLE DISEASES; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, BIOLOGICAL;

EID: 84878744789     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/297501     Document Type: Review

References (104)

1. Baumgart D. C., Sandborn W. J., Crohn's disease. The Lancet 2012 380 9853 1590 1605 10.1016/S0140-6736(12)60026-9
2. Radford-Smith G., Pandeya N., Associations between NOD2 / CARD15 genotype and phenotype in Crohn's disease-are we there yet? World Journal of Gastroenterology 2006 12 44 7097 7103 2-s2.0-33845400564 (Pubitemid 44890637)
3. Bonen D. K., Cho J. H., The genetics of inflammatory bowel disease. Gastroenterology 2003 124 2 521 536 2-s2.0-0037308263 10.1053/gast.2003.50045 (Pubitemid 36169267)
4. Yang S. K., Yun S., Kim J. H., Joon Y. P., Hak Y. K., Kim Y. H., Dong K. C., Joo S. K., In S. S., Jong B. P., Park E. R., Kyung J. K., Moon G., Soo H. Y., Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflammatory Bowel Diseases 2008 14 4 542 549 2-s2.0-42449141463 10.1002/ibd.20310 (Pubitemid 351571835)
5. Xavier R. J., Podolsky D. K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007 448 7152 427 434 2-s2.0-34547176642 10.1038/nature06005 (Pubitemid 47123518)
6. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., Gendre J. P., Long-term evolution of disease behavior of Crohn's disease. Inflammatory Bowel Diseases 2002 8 4 244 250 2-s2.0-0036061640 (Pubitemid 34784976)
7. Louis E., Collard A., Oger A. F., Degroote E., Aboul Nasr El Yafi F. A., Belaiche J., Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001 49 6 777 782 2-s2.0-0035188740 10.1136/gut.49.6.777 (Pubitemid 33096034)
8. Beaugerie L., Seksik P., Nion-Larmurier I., Gendre J. P., Cosnes J., Predictors of Crohn's disease. Gastroenterology 2006 130 3 650 656 2-s2.0-33644859927 10.1053/j.gastro.2005.12.019 (Pubitemid 43374514)
9. Heyman M. B., Kirschner B. S., Gold B. D., Ferry G., Baldassano R., Cohen S. A., Winter H. S., Fain P., King C., Smith T., El-Serag H. B., Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. Journal of Pediatrics 2005 146 1 35 40 2-s2.0-19944426172 10.1016/j.jpeds.2004.08.043 (Pubitemid 40091728)
10. Cannioto Z., Berti I., Martelossi S., Bruno I., Giurici N., Crovella S., Ventura A., IBD and IBD mimicking enterocolitis in children younger than 2 years of age. European Journal of Pediatrics 2009 168 2 149 155 2-s2.0-58149089639 10.1007/s00431-008-0721-2
11. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. Journal of Pediatric Gastroenterology and Nutrition 2005 41 1 1 7 2-s2.0-22044445381 10.1097/01.MPG.0000163736.30261.82 (Pubitemid 40967345)
12. Spray C., Debelle G. D., Murphy M. S., Current diagnosis, management and morbidity in paediatric inflammatory bowel disease. Acta Paediatrica 2001 90 4 400 405 2-s2.0-0035055905 (Pubitemid 32328459)
13. Lewis J. D., Abramson O., Pascua M., Liu L., Asakura L. M., Velayos F. S., Hutfless S. M., Alison J. E., Herrinton L. J., Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations. Clinical Gastroenterology and Hepatology 2009 7 11 1195 1201 2-s2.0-71749114818 10.1016/j.cgh.2009.07.019
14. Mitsuyama K., Tomiyasu N., Takaki K., Masuda J., Yamasaki H., Kuwaki K., Takeda T., Kitazaki S., Tsuruta O., Sata M., Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase. Mediators of Inflammation 2006 2006 7 2-s2.0-34248206040 10.1155/MI/2006/26875 26875 (Pubitemid 44826827)
15. Bickston S. J., Comerford L. W., Cominelli F., Future therapies for inflammatory bowel disease. Current Gastroenterology Reports 2003 5 6 518 523 2-s2.0-1542540146 (Pubitemid 38915053)
16. Hou J. K., El-Serag H., Thirumurthi S., Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. American Journal of Gastroenterology 2009 104 8 2100 2109 2-s2.0-68349157701 10.1038/ajg.2009.190
17. Abraham C., Cho J. H., Inflammatory bowel disease. The New England Journal of Medicine 2009 361 21 2066 2078 2-s2.0-70949107842 10.1056/NEJMra0804647
18. Barnich N., Carvalho F. A., Glasser A. L., Darcha C., Jantscheff P., Allez M., Peeters H., Bommelaer G., Desreumaux P., Colombel J. F., Darfeuille-Michaud A., CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. The Journal of Clinical Investigation 2007 117 6 1566 1574 2-s2.0-34249886868 10.1172/JCI30504 (Pubitemid 46871341)
19. Baumgart D. C., Sandborn W. J., Inflammatory bowel disease: clinical aspects and established and evolving therapies. The Lancet 2007 369 9573 1641 1657 2-s2.0-34248136340 10.1016/S0140-6736(07)60751-X (Pubitemid 46722637)
20. Podolsky D. K., The current future understanding of inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2002 16 6 933 943 2-s2.0-0036886298 10.1053/bega.2002.0354
21. Gutierrez A., Scharl M., Sempere L., Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease. Gut 2013 10.1136/gutjnl-2012/303557
22. Achkar J. P., Duerr R., The expanding universe of inflammatory bowel disease genetics. Current Opinion in Gastroenterology 2008 24 4 429 434 2-s2.0-66149176307 10.1097/MOG.0b013e3283009c92
23. Bodmer W., Tomlinson I., Rare genetic variants and the risk of cancer. Current Opinion in Genetics & Development 2010 20 3 262 267 2-s2.0-77953621982 10.1016/j.gde.2010.04.016
24. van Heel D. A., Ghosh S., Butler M., Hunt K. A., Lundberg A. M. C., Ahmad T., McGovern D. P. B., Onnie C., Negoro K., Goldthorpe S., Foxwell B. M. J., Mathew C. G., Forbes A., Jewell D. P., Playford R. J., Muramyl dipeptide and toll-like receptor sensitivity in NOD2 -associated Crohn's disease. The Lancet 2005 365 9473 1794 1796 2-s2.0-21144468350 10.1016/S0140-6736(05)66582-8 (Pubitemid 40744660)
25. van Limbergen J., Wilson D. C., Satsangi J., The genetics of Crohn's disease. Annual Review of Genomics and Human Genetics 2009 10 89 116 2-s2.0-69549148386 10.1146/annurev-genom-082908-150013
26. Lees C. W., Barrett J. C., Parkes M., Satsangi J., New IBD genetics: common pathways with other diseases. Gut 2011 60 12 1739 1753 10.1136/gut.2009.199679
27. Haglund S., Almer S., Peterson C., Söderman J., Gene expression and thiopurine metabolite profiling in inflammatory bowel disease-novel clues to drug targets and disease mechanisms? PLoS ONE 2013 8 2 e56989 10.1371/journal.pone.0056989
28. Hindorff L. A., Sethupathy P., Junkins H. A., Ramos E. M., Mehta J. P., Collins F. S., Manolio T. A., Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proceedings of the National Academy of Sciences of the United States of America 2009 106 23 9362 9367 2-s2.0-67249117049 10.1073/pnas.0903103106
29. Notarangelo L. D., Primary immunodeficiencies. The Journal of Allergy and Clinical Immunology 2010 125 2, supplement 2 S182 S194 2-s2.0-76749147849 10.1016/j.jaci.2009.07.053
30. Tommasini A., Pirrone A., Palla G., Taddio A., Martelossi S., Crovella S., Ventura A., The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease? Scandinavian Journal of Gastroenterology 2010 45 10 1141 1149 2-s2.0-77956602833 10.3109/00365521.2010.492529
31. de Ridder L., Weersma R. K., Dijkstra G., van der Steege G., Benninga M. A., Nolte I. M., Taminiau J. A. J. M., Hommes D. W., Stokkers P. C. F., Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflammatory Bowel Diseases 2007 13 9 1083 1092 2-s2.0-34548651642 10.1002/ibd.20171 (Pubitemid 47402591)
32. Biank V., Broeckel U., Kugathasan S., Pediatric inflammatory bowel disease: clinical and molecular genetics. Inflammatory Bowel Diseases 2007 13 11 1430 1438 2-s2.0-36749081017 10.1002/ibd.20213 (Pubitemid 350206858)
33. Lacher M., Kappler R., Berkholz S., Baurecht H., von Schweinitz D., Koletzko S., Association of a CXCL9 polymorphism with pediatric Crohn's disease. Biochemical and Biophysical Research Communications 2007 363 3 701 707 2-s2.0-34848826828 10.1016/j.bbrc.2007.09.020 (Pubitemid 47513686)
34. Glocker E. O., Kotlarz D., Boztug K., Gertz E. M., Schäffer A. A., Noyan F., Perro M., Diestelhorst J., Allroth A., Murugan D., Hätscher N., Pfeifer D., Sykora K. W., Sauer M., Kreipe H., Lacher M., Nustede R., Woellner C., Baumann U., Salzer U., Koletzko S., Shah N., Segal A. W., Sauerbrey A., Buderus S., Snapper S. B., Grimbacher B., Klein C., Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. The New England Journal of Medicine 2009 361 21 2033 2045 2-s2.0-70949087383 10.1056/NEJMoa0907206
35. Imielinski M., Baldassano R. N., Griffiths A., Russell R. K., Annese V., Dubinsky M., Kugathasan S., Bradfield J. P., Walters T. D., Sleiman P., Kim C. E., Muise A., Wang K., Glessner J. T., Saeed S., Zhang H., Frackelton E. C., Hou C., Flory J. H., Otieno G., Chiavacci R. M., Grundmeier R., Castro M., Latiano A., Dallapiccola B., Stempak J., Abrams D. J., Taylor K., McGovern D., Heyman M. B., Ferry G. D., Kirschner B., Lee J., Essers J., Grand R., Stephens M., Levine A., Piccoli D., van Limbergen J., Cucchiara S., Monos D. S., Guthery S. L., Denson L., Wilson D. C., Grant S. F. A., Daly M., Silverberg M. S., Satsangi J., Hakonarson H., Common variants at five new loci associated with early-onset inflammatory bowel disease. Nature Genetics 2009 41 12 1335 1340 2-s2.0-70649113728 10.1038/ng.489
36. Amre D. K., Mack D. R., Morgan K., Israel D., Deslandres C., Seidman E. G., Lambrette P., Costea I., Krupoves A., Fegury H., Dong J., Xhu Z., Grimard G., Levy E., Association between genome-wide association studies reported SNPs and pediatric-onset Crohn's disease in Canadian children. Human Genetics 2010 128 2 131 135 2-s2.0-77955285576 10.1007/s00439-010-0835-2
37. Helbig K. L., Nothnagel M., Hampe J., A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology. BMC Medical Genetics 2012 13, article 14
38. Kunz C., Kuntz S., Rudloff S., Intestinal flora. Advances in Experimental Medicine and Biology 2009 639 67 79 2-s2.0-62749154624 10.1007/978-1-4020-8749- 3-6
39. Whitman W. B., Coleman D. C., Wiebe W. J., Prokaryotes: the unseen majority. Proceedings of the National Academy of Sciences of the United States of America 1998 95 12 6578 6583 2-s2.0-0032499758 10.1073/pnas.95.12.6578 (Pubitemid 28278022)
40. Ley R. E., Peterson D. A., Gordon J. I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006 124 4 837 848 2-s2.0-32944466887 10.1016/j.cell.2006.02.017 (Pubitemid 43261456)
41. Verstraelen H., Cutting edge: the vaginal microflora and bacterial vaginosis. Verhandelingen-Koninklijke Academie voor Geneeskunde van België 2008 70 3 147 174 2-s2.0-49649092913
42. Gordon J. I., Honor thy gut symbionts redux. Science 2012 336 6086 1251 1253 10.1126/science.1224686
43. Frank D. N., St Amand A. L., Feldman R. A., Boedeker E. C., Harpaz N., Pace N. R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13780 13785 2-s2.0-35348857386 10.1073/pnas.0706625104 (Pubitemid 350003397)
44. Redondo-Lopez V., Cook R. L., Sobel J. D., Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Reviews of Infectious Diseases 1990 12 5 856 872 2-s2.0-0025114171 (Pubitemid 20349968)
45. Huurre A., Kalliomäki M., Rautava S., Rinne M., Salminen S., Isolauri E., Mode of delivery-effects on gut microbiota and humoral immunity. Neonatology 2008 93 4 236 240 2-s2.0-44849102151 10.1159/000111102 (Pubitemid 351799101)
46. Zoetendal E. G., von Wright A., Vilpponen-Salmela T., Ben-Amor K., Akkermans A. D. L., de Vos W. M., Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Applied and Environmental Microbiology 2002 68 7 3401 3407 2-s2.0-0036300743 10.1128/AEM.68.7.3401-3407.2002 (Pubitemid 34734038)
47. Ley R. E., Bäckhed F., Turnbaugh P., Lozupone C. A., Knight R. D., Gordon J. I., Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 2005 102 31 11070 11075 2-s2.0-23344442120 10.1073/pnas.0504978102 (Pubitemid 41105994)
48. Zhang C., Zhang M., Wang S., Han R., Cao Y., Hua W., Mao Y., Zhang X., Pang X., Wei C., Zhao G., Chen Y., Zhao L., Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. The ISME Journal 2010 4 2 232 241 2-s2.0-76349111356 10.1038/ismej.2009.112
49. Rakoff-Nahoum S., Medzhitov R., Innate immune recognition of the indigenous microbial flora. Mucosal Immunology 2008 1 supplement 1 S10 S14 2-s2.0-54349126459 10.1038/mi.2008.49
50. Eckburg P. B., Bik E. M., Bernstein C. N., Purdom E., Dethlefsen L., Sargent M., Gill S. R., Nelson K. E., Relman D. A., Diversity of the human intestinal microbial flora. Science 2005 308 5728 1635 1638 2-s2.0-20544444045 10.1126/science.1110591 (Pubitemid 40807514)
51. Baumgart M., Dogan B., Rishniw M., Weitzman G., Bosworth B., Yantiss R., Orsi R. H., Wiedmann M., McDonough P., Kim S. G., Berg D., Schukken Y., Scherl E., Simpson K. W., Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. The ISME Journal 2007 1 5 403 418 2-s2.0-34548483459 10.1038/ismej.2007.52 (Pubitemid 47373247)
52. Li E., Hamm C. M., Gulati A. S., Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS ONE 2012 7 6 e26284
53. Sokol H., Seksik P., The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Current Opinion in Gastroenterology 2010 26 4 327 331 2-s2.0-77954142534 10.1097/MOG.0b013e328339536b
54. Joossens M., Huys G., Cnockaert M., de Preter V., Verbeke K., Rutgeerts P., Vandamme P., Vermeire S., Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011 60 5 631 637 2-s2.0-79953748870 10.1136/gut.2010.223263
55. Virgin H. W., Wherry E. J., Ahmed R., Redefining chronic viral infection. Cell 2009 138 1 30 50 2-s2.0-67649660551 10.1016/j.cell.2009.06.036
56. Elinav E., Henao-Mejia J., Flavell R. A., Integrative inflammasome activity in the regulation of intestinal mucosal immune responses. Mucosal Immunology 2013 6 1 4 13 10.1038/mi.2012.115
57. Frank D. N., Robertson C. E., Hamm C. M., Kpadeh Z., Zhang T., Chen H., Zhu W., Sartor R. B., Boedeker E. C., Harpaz N., Pace N. R., Li E., Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflammatory Bowel Diseases 2011 17 1 179 184 2-s2.0-78650099360 10.1002/ibd.21339
58. Gophna U., Sommerfeld K., Gophna S., Doolittle W. F., Veldhuyzen van Zanten S. J. O., Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. Journal of Clinical Microbiology 2006 44 11 4136 4141 2-s2.0-33750956239 10.1128/JCM.01004-06 (Pubitemid 44737260)
59. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P., Roca J., Dore J., Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006 55 2 205 211 2-s2.0-30944466824 10.1136/gut.2005.073817 (Pubitemid 43117279)
60. Cadwell K., Crohn's disease susceptibility gene interactions, a NOD to the newcomer ATG16L1. Gastroenterology 2010 139 5 1448 1450 2-s2.0-78049485275 10.1053/j.gastro.2010.09.023
61. Glubb D. M., Gearry R. B., Barclay M. L., Roberts R. L., Pearson J., Keenan J. I., Mckenzie J., Bentley R. W., NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease. World Journal of Gastroenterology 2011 17 23 2829 2837 2-s2.0-79959655886 10.3748/wjg.v17.i23.2829
62. Ting J. P. Y., Kastner D. L., Hoffman H. M., CATERPILLERs, pyrin and hereditary immunological disorders. Nature Reviews Immunology 2006 6 3 183 195 2-s2.0-33344476398 10.1038/nri1788 (Pubitemid 43290988)
63. Brand S., Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009 58 8 1152 1167 2-s2.0-67650224449 10.1136/gut.2008.163667
64. Plantinga T. S., Joosten L. A., van der Meer J. W., Netea M. G., Modulation of inflammation by autophagy: consequences for Crohn's disease. Current Opinion in Pharmacology 2012 12 4 497 502 10.1016/j.coph.2012.01.017
65. Levine B., Deretic V., Unveiling the roles of autophagy in innate and adaptive immunity. Nature Reviews Immunology 2007 7 10 767 777 2-s2.0-34548700796 10.1038/nri2161 (Pubitemid 47480305)
66. Deretic V., Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Current Opinion in Immunology 2012 24 1 21 31 10.1016/j.coi.2011.10.006
67. Villani A. C., Lemire M., Fortin G., Louis E., Silverberg M. S., Collette C., Baba N., Libioulle C., Belaiche J., Bitton A., Gaudet D., Cohen A., Langelier D., Fortin P. R., Wither J. E., Sarfati M., Rutgeerts P., Rioux J. D., Vermeire S., Hudson T. J., Franchimont D., Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nature Genetics 2009 41 1 71 76 2-s2.0-58149159542 10.1038/ng.285
68. Ferrero-Miliani L., Nielsen O. H., Andersen P. S., Girardin S. E., Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1 β generation. Clinical and Experimental Immunology 2007 147 2 227 235 2-s2.0-33846257261 10.1111/j.1365-2249.2006.03261.x (Pubitemid 46095999)
69. Gombault A., Baron L., Couillin I., ATP release and purinergic signaling in NLRP3 inflammasome activation. Frontiers in Immunology 2012 3, article 414
70. Kanneganti T. D., Özören N., Body-Malapel M., Amer A., Park J. H., Franchi L., Whitfield J., Barchet W., Colonna M., Vandenabeele P., Bertin J., Coyle A., Grant E. P., Akira S., Núñez G., Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/ NALP3. Nature 2006 440 7081 233 236 2-s2.0-32944462834 10.1038/nature04517 (Pubitemid 43372103)
71. Kingsbury S. R., Conaghan P. G., McDermott M. F., The role of the NLRP3 inflammasome in gout. Journal of Inflammation Research 2011 4 1 39 49 2-s2.0-79952950889 10.2147/JIR.S11330
72. Martinon F., Agostini L., Meylan E., Tschopp J., Identification of bacterial muramyl dipeptide as activator of the NALP3 /cryopyrin inflammasome. Current Biology 2004 14 21 1929 1934 2-s2.0-7944232105 10.1016/j.cub.2004.10.027 (Pubitemid 39464816)
73. Mariathasan S., Monack D. M., Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nature Reviews Immunology 2007 7 1 31 40 2-s2.0-33845890803 10.1038/nri1997 (Pubitemid 46020825)
74. Elinav E., Strowig T., Kau A. L., Henao-Mejia J., Thaiss C. A., Booth C. J., Peaper D. R., Bertin J., Eisenbarth S. C., Gordon J. I., Flavell R. A., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011 145 5 745 757 2-s2.0-79957576718 10.1016/j.cell.2011.04.022
75. von Kampen O., Lipinski S., Till A., Martin S. J., Nietfeld W., Lehrach H., Schreiber S., Rosenstiel P., Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2 -mediated signaling. The Journal of Biological Chemistry 2010 285 26 19921 19926 2-s2.0-77953733399 10.1074/jbc.M110.127480
76. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., Albrecht M., Mayr G., de La Vega F. M., Briggs J., Günther S., Prescott N. J., Onnie C. M., Häsler R., Sipos B., Fölsch U. R., Lengauer T., Platzer M., Mathew C. G., Krawczak M., Schreiber S., A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nature Genetics 2007 39 2 207 211 2-s2.0-33846627302 10.1038/ng1954 (Pubitemid 46184351)
77. McCarroll S. A., Huett A., Kuballa P., Chilewski S. D., Landry A., Goyette P., Zody M. C., Hall J. L., Brant S. R., Cho J. H., Duerr R. H., Silverberg M. S., Taylor K. D., Rioux J. D., Altshuler D., Daly M. J., Xavier R. J., Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nature Genetics 2008 40 9 1107 1112 2-s2.0-50449091647 10.1038/ng.215
78. Cooney R., Baker J., Brain O., Danis B., Pichulik T., Allan P., Ferguson D. J. P., Campbell B. J., Jewell D., Simmons A., NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nature Medicine 2010 16 1 90 97 2-s2.0-73849151394 10.1038/nm.2069
79. Travassos L. H., Carneiro L. A. M., Ramjeet M., Hussey S., Kim Y. G., Magalhes J. G., Yuan L., Soares F., Chea E., Le Bourhis L., Boneca I. G., Allaoui A., Jones N. L., Nũez G., Girardin S. E., Philpott D. J., Nod1 and NOD2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nature Immunology 2010 11 1 55 62 2-s2.0-73849121209 10.1038/ni.1823
80. Glick D., Barth S., Macleod K. F., Autophagy: cellular and molecular mechanisms. The Journal of Pathology 2010 221 1 3 12 2-s2.0-77950994646 10.1002/path.2697
81. Huett A., Xavier R. J., Autophagy at the gut interface: mucosal responses to stress and the consequences for inflammatory bowel diseases. Inflammatory Bowel Diseases 2010 16 1 152 174 2-s2.0-74049108115 10.1002/ibd.20991
82. Yuk J. M., Yoshimori T., Jo E. K., Autophagy and bacterial infectious diseases. Experimental & Molecular Medicine 2012 44 2 99 108 10.3858/emm.2012.44.2.032
83. Homer C. R., Richmond A. L., Rebert N. A., Achkar J., McDonald C., ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 2010 139 5 1630.e2 1641.e2 2-s2.0-77957682295 10.1053/j.gastro.2010.07.006
84. Miller B. C., Zhao Z., Stephenson L. M., Cadwell K., Pua H. H., Lee H. K., Mizushima N., Iwasaki A., He Y. W., Swat W., Virgin H. W., The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 2008 4 3 309 314 2-s2.0-41449106674 (Pubitemid 351458091)
85. Rosenstiel P., Jacobs G., Till A., Schreiber S., NOD-like receptors: ancient sentinels of the innate immune system. Cellular and Molecular Life Sciences 2008 65 9 1361 1377 2-s2.0-43049174584 10.1007/s00018-008-7502-y
86. Ott S. J., Musfeldt M., Wenderoth D. F., Hampe J., Brant O., Fölsch U. R., Timmis K. N., Schreiber S., Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004 53 5 685 693 2-s2.0-2342442430 10.1136/gut.2003.025403 (Pubitemid 38561447)
87. Qin J., Li R., Raes J., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010 464 7285 59 65 10.1038/nature08821
88. Kanaan Z. M., Eichenberger M. R., Ahmad S., Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population. Journal of Negative Results in Biomedicine 2012 11, article 7 10.1186/1477-5751-11-7
89. Lesage S., Zouali H., Cezard J. P., CARD15 / NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. The American Journal of Human Genetics 2002 70 4 845 857 10.1086/339432 (Pubitemid 34259301)
90. Petnicki-Ocwieja T., Hrncir T., Liu Y. J., Biswas A., Hudcovic T., Tlaskalova-Hogenova H., Kobayashi K. S., NOD2 is required for the regulation of commensal microbiota in the intestine. Proceedings of the National Academy of Sciences of the United States of America 2009 106 37 15813 15818 2-s2.0-70349468054 10.1073/pnas.0907722106
91. Kuballa P., Huett A., Rioux J. D., Daly M. J., Xavier R. J., Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS ONE 2008 3 10 2-s2.0-54849421128 10.1371/journal.pone. 0003391 e3391
92. Kim Y. G., Kamada N., Shaw M. H., Warner N., Chen G. Y., Franchi L., Núñez G., The NOD2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 2011 34 5 769 780 2-s2.0-79956319462 10.1016/j.immuni.2011.04.013
93. Parkes M., Barrett J. C., Prescott N. J., Tremelling M., Anderson C. A., Fisher S. A., Roberts R. G., Nimmo E. R., Cummings F. R., Soars D., Drummond H., Lees C. W., Khawaja S. A., Bagnall R., Burke D. A., Todhunter C. E., Ahmad T., Onnie C. M., McArdle W., Strachan D., Bethel G., Bryan C., Lewis C. M., Deloukas P., Forbes A., Sanderson J., Jewell D. P., Satsangi J., Mansfield J. C., Cardon L., Mathew C. G., Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nature Genetics 2007 39 7 830 832 2-s2.0-34347338690 10.1038/ng2061 (Pubitemid 47014496)
94. Brest P., Lapaquette P., Souidi M., Lebrigand K., Cesaro A., Vouret-Craviari V., Mari B., Barbry P., Mosnier J. F., Hébuterne X., Harel-Bellan A., Mograbi B., Darfeuille-Michaud A., Hofman P., A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nature Genetics 2011 43 3 242 245 2-s2.0-79952134938 10.1038/ng.762
95. Darfeuille-Michaud A., Neut C., Barnich N., Lederman E., Di Martino P., Desreumaux P., Gambiez L., Joly B., Cortot A., Colombel J. F., Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998 115 6 1405 1413 2-s2.0-0031758230 (Pubitemid 28545991)
96. Singh S. B., Ornatowski W., Vergne I., Naylor J., Delgado M., Roberts E., Ponpuak M., Master S., Pilli M., White E., Komatsu M., Deretic V., Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nature Cell Biology 2010 12 12 1154 1165 2-s2.0-78649833818 10.1038/ncb2119
97. Gregoire I. P., Richetta C., Meyniel-Schicklin L., IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathogens 2011 7 12 e1002422
98. Papa E., Docktor M., Smillie C., Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS ONE 2012 7 6 e39242
99. Ayling R. M., New faecal tests in gastroenterology. Annals of Clinical Biochemistry 2012 49, part 1 44 54 10.1258/acb.2011.011150
100. van Rheenen P. F., van de Vijver E., Fidler V., Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. British Medical Journal 2010 341 c3369 2-s2.0-77954964440 10.1136/bmj.c3369
101. Vitali R., Stronati L., Negroni A., Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. The American Journal of Gastroenterology 2011 106 11 2029 2040 10.1038/ajg.2011.231
102. Ehlers S., Kaufmann S. H. E., Participants of the 99th Dahlem Conference, Infection, inflammation, and chronic diseases: consequences of a modern lifestyle. Trends in Immunology 2010 31 5 184 190 2-s2.0-77951622993 10.1016/j.it.2010.02.003
103. Marcuzzi A., Girardelli M., Bianco A. M., Inflammation profile of four early onset Crohn patients. Gene 2012 493 2 282 285
104. Bianco A. M., Zanin V., Girardelli M., A common genetic background could explain early-onset Crohn's disease. Medical Hyphoteses 2012 78 4 520 522